Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
Superinvestors holding IMCR, Q2 2026
No superinvestor reported holding IMCR in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of IMCR each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2022
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−0.7%)